| | 941678-49-5 Basic information More.. |
| Product Name: | Ruxolitinib | | Synonyms: | (betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile;(3R)-3-(4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile;(3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyriMidin-4-yl}-1H-pyrazol-1-yl)propanenitrile;INCB018424 (Ruxolitinib);β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-(βR)-1H-pyrazole-1-propanenitrile;(βR)-β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazole-1-propanenitrile;Ruxolitinib(INCB-018424);1H-Pyrazole-1-propanenitrile,.beta.-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-,(.beta.R)- | | CAS: | 941678-49-5 | | MF: | C17H18N6 | | MW: | 306.37 | | EINECS: | 1312995-182-4 | | Mol File: | 941678-49-5.mol |  |
Use
Ruxolitinib is a small-molecule inhibitor of the tyrosine kinase (namely, jak1 and jak2) and is suitable for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post essential thrombocythemia myelofibrosis.
- Ruxolitinib
-
- US $53.00-93.00 / mg
- 2024-11-19
- CAS:941678-49-5
- Min. Order:
- Purity: 99.93%
- Supply Ability: 10g
- Ruxolitinib
-
- US $0.00 / g
- 2024-11-19
- CAS:941678-49-5
- Min. Order: 1g
- Purity: 98% HPLC
- Supply Ability: 100kg
- Ruxolitinib
-
- US $254.00 / g/Bag
- 2024-11-14
- CAS:941678-49-5
- Min. Order: 1g
- Purity: 98%
- Supply Ability: 10kg
|
|
941678-49-5
Recommend Suppliers |
|